Takayasu's Arteritis and Crohn's Disease in a Young Hispanic Female

Namrata Singh1, Shireesh Saurabh2, Irene J Tan3

  • 1Immunology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, C42 E 10, Iowa City, IA 52241, USA.

Insights

Takayasu arteritis and Crohn's disease co-occurred in a young Hispanic female. Interleukin 12 B (IL-12B) may be a shared autoimmune mechanism and therapeutic target for these rare inflammatory conditions.

Area of Science:

  • Immunology
  • Genetics
  • Vascular Medicine

Background:

  • Takayasu arteritis (TA) and Crohn's disease (CD) are chronic inflammatory granulomatous disorders.
  • TA affects large vessels, primarily the aorta, in young Asian women.
  • CD primarily affects the gastrointestinal tract, more common in young Caucasians.

Purpose of the Study:

  • To describe a rare co-occurrence of Takayasu arteritis and Crohn's disease in a young Hispanic female.
  • To review existing literature on this rare disease combination.
  • To explore potential genetic linkage and shared autoimmune mechanisms, focusing on IL-12B.

Main Methods:

  • Case report of a young Hispanic female diagnosed with both TA and CD.
  • Comprehensive literature review of co-existing TA and CD.
  • Analysis of potential genetic factors and immunological pathways, including IL-12B.

Main Results:

  • Detailed presentation of a unique case of TA and CD in a young Hispanic patient.
  • Identification of limited existing literature on this specific comorbidity.
  • Hypothesized role of IL-12B as a common autoimmune pathway.

Conclusions:

  • The co-occurrence of TA and CD is exceptionally rare.
  • Interleukin 12 B (IL-12B) presents a potential common autoimmune mechanism.
  • IL-12B may represent a novel therapeutic target for patients with both TA and CD.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
25
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
867
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
27
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
744
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
893